In vitro suppression of immune responses using monocyte-derived tolerogenic dendritic cells from patients with primary Sjögren's syndrome

INTRODUCTION: Therapeutic vaccination with antigen-specific tolerogenic dendritic cells (tolDC) might become a future option of individualized therapy for patients with autoimmune diseases. In this study, we tested the possibility of generating monocyte-derived tolDC from patients with primary Sjögr...

Descripción completa

Detalles Bibliográficos
Autores principales: Volchenkov, Roman, Brun, Johan G, Jonsson, Roland, Appel, Silke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3978468/
https://www.ncbi.nlm.nih.gov/pubmed/24025795
http://dx.doi.org/10.1186/ar4294

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3978468/
https://www.ncbi.nlm.nih.gov/pubmed/24025795
http://dx.doi.org/10.1186/ar4294

Ejemplares similares